ENN-38125-40152
4 vaccinations
5 coded responses
32 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 810 / CO
- Registered
- 2021-01-05
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-05
Registered in v-safe
-
2021-01-05
Dose 1 — Moderna
- 2021-01-05
-
2021-01-06
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Chills, Muscle or body achesAdult check-in
- 2021-01-07
- 2021-01-08
- 2021-01-09
- 2021-01-10
- 2021-01-11
- 2021-01-12
- 2021-01-20
- 2021-01-26
- 2021-02-02
-
2021-02-05
Dose 2 — Moderna
-
2021-02-09
Survey response — days 1–6 daily, dose 2MedDRA: Fatigue, Injection site pain, Malaise — Feeling: Good · Site: Itching · Fatigue or tirednessFree text: 36 hours after second immunization I had profound fatigue, injection site pain and generalized malaise Would rate as moderateMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-10
-
2021-02-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, NauseaAdult check-in
-
2021-02-12
Survey response — day 7, dose 2MedDRA: Anxiety, Sleep disorder — Feeling: GoodFree text: Anxiety awaking me from sleepMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-19
-
2021-02-27
Survey response — day 21, dose 2MedDRA: Fatigue, Injection site pain, Insomnia, Neuralgia — Feeling: FairFree text: Fatigue. Insomnia. Pain at injection site. Fleeting neuropathic pain right ankle.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-05
- 2021-03-12
-
2021-03-19
Survey response — day 42, dose 2MedDRA: Greater trochanteric pain syndrome — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Right greater trochanter bursitis.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Report sent to call center — day 42, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-09
- 2021-08-06
-
2021-10-31
Dose 3 — Moderna
- 2021-12-23
- 2022-02-05
- 2022-02-05
- 2022-05-03
-
2022-10-31
Survey response — 12 months, dose 3MedDRA: Chills, Fatigue, Myalgia, Pyrexia, SARS-CoV-2 test positive — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Fever, chills, myalgias and severe fatigue 8/6/22. Positive Covid test. Treated with Paxlovid. Uneventful recovery after three days.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-31
Report sent to call center — 12 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-11-01
- 2022-11-01
-
2022-11-25
Dose 4 — Moderna
- 2022-12-21
- 2022-12-23
- 2022-12-30
- 2023-01-06
- 2023-02-24
- 2023-05-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-05 | Moderna | |
| 2 | 2021-02-05 | Moderna | |
| 3 | 2021-10-31 | Moderna | No |
| 4 | 2022-11-25 | Moderna | No |
Call center
2 call center cases
2 unsuccessful
1 wait over 3 months for a first call
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): 36 hours after second immunization I had profound fatigue, injection site pain and generalized malaise Would rate as moderate
Release 4 — day 7, dose 2
Systemic reaction (other): Anxiety awaking me from sleep
Release 4 — day 21, dose 2
Symptoms: Fatigue. Insomnia. Pain at injection site. Fleeting neuropathic pain right ankle.
Release 5 — day 42, dose 2
Symptoms: Right greater trochanter bursitis.
Release 12 — 12 months, dose 3
Symptoms: Fever, chills, myalgias and severe fatigue 8/6/22. Positive Covid test. Treated with Paxlovid. Uneventful recovery after three days.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Greater trochanteric pain syndrome | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Insomnia | ✓ | ✓ | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Neuralgia | ✓ | ✓ | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Anxiety | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Malaise | ✓ | ✓ | ✓ |
| SRO | Sleep disorder | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release